ALEMBIC
|
ALEMBIC Last 5 Year Balance Sheet History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹51 Cr | ₹51 Cr | ₹51 Cr | ₹51 Cr | ₹51 Cr |
Equity - Authorised | ₹60 Cr | ₹60 Cr | ₹60 Cr | ₹60 Cr | ₹60 Cr |
Equity - Issued | ₹51 Cr | ₹51 Cr | ₹51 Cr | ₹51 Cr | ₹51 Cr |
Equity Paid Up | ₹51 Cr | ₹51 Cr | ₹51 Cr | ₹51 Cr | ₹51 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹2.00 | ₹2.00 | ₹2.00 | ₹2.00 | ₹2.00 |
Share Warrants & Outstandings | - | - | - | - | - |
Total Reserves | ₹2,134 Cr | ₹2,027 Cr | ₹2,445 Cr | ₹2,246 Cr | ₹1,367 Cr |
Securities Premium | ₹212 Cr | ₹212 Cr | ₹212 Cr | ₹212 Cr | - |
Capital Reserves | - | - | - | - | - |
Profit & Loss Account Balance | ₹1,481 Cr | ₹1,316 Cr | ₹1,517 Cr | ₹1,444 Cr | ₹954 Cr |
General Reserves | ₹165 Cr | ₹165 Cr | ₹165 Cr | ₹145 Cr | ₹289 Cr |
Other Reserves | ₹277 Cr | ₹334 Cr | ₹552 Cr | ₹445 Cr | ₹124 Cr |
Reserve excluding Revaluation Reserve | ₹2,134 Cr | ₹2,027 Cr | ₹2,445 Cr | ₹2,246 Cr | ₹1,367 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹2,186 Cr | ₹2,078 Cr | ₹2,497 Cr | ₹2,297 Cr | ₹1,418 Cr |
Minority Interest | - | - | - | - | - |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | ₹7.39 Cr | - | - | - | - |
Non Convertible Debentures | - | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | ₹9.15 Cr | - | - | - | - |
Term Loans - Institutions | - | - | - | - | - |
Other Secured | ₹-1.76 Cr | - | - | - | - |
Unsecured Loans | - | - | - | - | - |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | - | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | - | - | - | - | - |
Other Unsecured Loan | - | - | - | - | - |
Deferred Tax Assets / Liabilities | ₹32 Cr | ₹35 Cr | ₹60 Cr | ₹47 Cr | ₹1.69 Cr |
Deferred Tax Assets | ₹4.42 Cr | ₹7.00 Cr | ₹4.15 Cr | ₹3.08 Cr | ₹3.42 Cr |
Deferred Tax Liability | ₹37 Cr | ₹42 Cr | ₹65 Cr | ₹50 Cr | ₹5.11 Cr |
Other Long Term Liabilities | ₹11 Cr | ₹6.70 Cr | ₹6.03 Cr | ₹5.07 Cr | ₹4.50 Cr |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | ₹1.91 Cr | ₹1.21 Cr | ₹1.10 Cr | ₹0.83 Cr | ₹0.70 Cr |
Total Non-Current Liabilities | ₹53 Cr | ₹43 Cr | ₹68 Cr | ₹53 Cr | ₹6.88 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹31 Cr | ₹17 Cr | ₹19 Cr | ₹18 Cr | ₹13 Cr |
Sundry Creditors | ₹31 Cr | ₹17 Cr | ₹19 Cr | ₹18 Cr | ₹13 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹33 Cr | ₹45 Cr | ₹36 Cr | ₹31 Cr | ₹22 Cr |
Bank Overdraft / Short term credit | - | - | - | - | ₹0.03 Cr |
Advances received from customers | ₹19 Cr | ₹34 Cr | ₹27 Cr | ₹22 Cr | ₹14 Cr |
Interest Accrued But Not Due | - | - | - | - | - |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | - |
Other Liabilities | ₹14 Cr | ₹11 Cr | ₹8.92 Cr | ₹8.59 Cr | ₹8.19 Cr |
Short Term Borrowings | - | - | - | ₹0.28 Cr | - |
Secured ST Loans repayable on Demands | - | - | - | ₹0.28 Cr | - |
Working Capital Loans- Sec | - | - | - | ₹0.28 Cr | - |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | - | - | - | ₹-0.28 Cr | - |
Short Term Provisions | ₹32 Cr | ₹27 Cr | ₹13 Cr | ₹11 Cr | ₹11 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | ₹11 Cr | ₹5.75 Cr | ₹2.04 Cr | - | - |
Provision for post retirement benefits | - | - | - | - | - |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹21 Cr | ₹21 Cr | ₹11 Cr | ₹11 Cr | ₹11 Cr |
Total Current Liabilities | ₹96 Cr | ₹90 Cr | ₹68 Cr | ₹59 Cr | ₹46 Cr |
Total Liabilities | ₹2,335 Cr | ₹2,210 Cr | ₹2,632 Cr | ₹2,409 Cr | ₹1,471 Cr |
ASSETS | |||||
Gross Block | ₹152 Cr | ₹151 Cr | ₹151 Cr | ₹150 Cr | ₹145 Cr |
Less: Accumulated Depreciation | ₹21 Cr | ₹19 Cr | ₹18 Cr | ₹16 Cr | ₹15 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹131 Cr | ₹132 Cr | ₹134 Cr | ₹134 Cr | ₹131 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | ₹1.10 Cr | ₹0.13 Cr | ₹0.19 Cr | ₹37 Cr | ₹19 Cr |
Non Current Investments | ₹1,775 Cr | ₹1,708 Cr | ₹2,182 Cr | ₹2,031 Cr | ₹1,079 Cr |
Long Term Investment | ₹1,775 Cr | ₹1,708 Cr | ₹2,182 Cr | ₹2,031 Cr | ₹1,079 Cr |
Quoted | ₹1,775 Cr | ₹1,708 Cr | ₹2,182 Cr | ₹2,031 Cr | ₹1,079 Cr |
Unquoted | ₹0.02 Cr | ₹0.02 Cr | ₹0.02 Cr | ₹0.02 Cr | ₹0.02 Cr |
Long Term Loans & Advances | ₹36 Cr | ₹1.22 Cr | ₹6.54 Cr | ₹1.95 Cr | ₹0.86 Cr |
Other Non Current Assets | ₹11 Cr | ₹1.64 Cr | ₹2.67 Cr | ₹3.52 Cr | - |
Total Non-Current Assets | ₹2,191 Cr | ₹2,032 Cr | ₹2,489 Cr | ₹2,307 Cr | ₹1,308 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | ₹11 Cr | ₹45 Cr | ₹26 Cr | ₹17 Cr | ₹54 Cr |
Quoted | ₹11 Cr | ₹45 Cr | ₹21 Cr | ₹13 Cr | ₹54 Cr |
Unquoted | - | - | ₹4.49 Cr | ₹3.67 Cr | - |
Inventories | ₹93 Cr | ₹89 Cr | ₹87 Cr | ₹54 Cr | ₹35 Cr |
Raw Materials | ₹1.58 Cr | ₹3.27 Cr | ₹1.52 Cr | ₹3.18 Cr | ₹2.31 Cr |
Work-in Progress | ₹84 Cr | ₹77 Cr | ₹77 Cr | ₹41 Cr | ₹25 Cr |
Finished Goods | ₹4.72 Cr | ₹5.24 Cr | ₹4.64 Cr | ₹7.10 Cr | ₹4.71 Cr |
Packing Materials | ₹0.05 Cr | ₹0.03 Cr | ₹0.05 Cr | ₹0.06 Cr | ₹0.07 Cr |
Stores  and Spare | ₹2.58 Cr | ₹2.91 Cr | ₹3.28 Cr | ₹3.29 Cr | ₹3.36 Cr |
Other Inventory | - | - | - | - | - |
Sundry Debtors | ₹20 Cr | ₹23 Cr | ₹15 Cr | ₹14 Cr | ₹8.98 Cr |
Debtors more than Six months | ₹3.06 Cr | ₹1.65 Cr | ₹0.17 Cr | ₹0.31 Cr | - |
Debtors Others | ₹17 Cr | ₹22 Cr | ₹15 Cr | ₹14 Cr | ₹9.63 Cr |
Cash and Bank | ₹2.47 Cr | ₹1.90 Cr | ₹1.85 Cr | ₹6.57 Cr | ₹59 Cr |
Cash in hand | ₹0.01 Cr | ₹0.01 Cr | ₹0.02 Cr | ₹0.03 Cr | ₹0.02 Cr |
Balances at Bank | ₹2.46 Cr | ₹1.89 Cr | ₹1.82 Cr | ₹6.54 Cr | ₹59 Cr |
Other cash and bank balances | - | - | - | - | - |
Other Current Assets | ₹3.92 Cr | ₹8.95 Cr | ₹3.89 Cr | ₹2.11 Cr | ₹1.48 Cr |
Interest accrued on Investments | - | - | - | - | - |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | - | - | - | - | - |
Prepaid Expenses | ₹0.74 Cr | ₹0.29 Cr | ₹0.42 Cr | ₹0.74 Cr | ₹0.55 Cr |
Other current_assets | ₹3.18 Cr | ₹8.66 Cr | ₹3.47 Cr | ₹1.38 Cr | ₹0.93 Cr |
Short Term Loans and Advances | ₹13 Cr | ₹9.57 Cr | ₹9.65 Cr | ₹8.73 Cr | ₹4.38 Cr |
Advances recoverable in cash or in kind | ₹5.16 Cr | ₹2.31 Cr | ₹4.00 Cr | ₹6.86 Cr | ₹2.32 Cr |
Advance income tax and TDS | ₹5.80 Cr | ₹6.53 Cr | - | ₹0.37 Cr | ₹0.98 Cr |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | ₹5.04 Cr | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹2.15 Cr | ₹0.73 Cr | ₹0.61 Cr | ₹1.50 Cr | ₹1.08 Cr |
Total Current Assets | ₹143 Cr | ₹178 Cr | ₹143 Cr | ₹102 Cr | ₹163 Cr |
Net Current Assets (Including Current Investments) | ₹47 Cr | ₹88 Cr | ₹76 Cr | ₹43 Cr | ₹117 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹2,335 Cr | ₹2,210 Cr | ₹2,632 Cr | ₹2,409 Cr | ₹1,471 Cr |
Contingent Liabilities | ₹34 Cr | ₹48 Cr | ₹40 Cr | ₹48 Cr | ₹47 Cr |
Total Debt | ₹9.15 Cr | - | - | ₹0.28 Cr | - |
Book Value | 85.11 | 80.93 | 97.23 | 89.45 | 55.22 |
Adjusted Book Value | 85.11 | 80.93 | 97.23 | 89.45 | 55.22 |
Compare Balance Sheet of peers of ALEMBIC
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ALEMBIC | ₹3,582.4 Cr | -5.5% | 13% | 56.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹433,920.0 Cr | -0.1% | 1.7% | 45.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹155,160.0 Cr | -0.1% | -2.2% | 56.9% | Stock Analytics | |
CIPLA | ₹118,917.0 Cr | 1.7% | 0.5% | 23.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹112,017.0 Cr | 5.7% | 12.4% | 18.5% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,997.1 Cr | -1.4% | 3.1% | 44.8% | Stock Analytics |
ALEMBIC Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ALEMBIC | -5.5% |
13% |
56.2% |
SENSEX | -5% |
0.6% |
9.2% |
You may also like the below Video Courses